[1]
T. Mazhindu, “Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe”, S Afr Med J, vol. 116, no. 5, p. e3655, Jun. 2026, doi: 10.7196/SAMJ.2026.v116i5.3655.